Trial intelligence / Profile preview

Low-dose ketamine as an adjunct to morphine for acute pain in the Emergency Department

2021-005116-64Phase 4Terminated

Sponsor
Aarhus University Hospital
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketamine in acute pain (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Primary pain reduction at 10 minutes. Started Oct 2021; status: terminated.

02

Drugs

ketamine
03

Conditions

acute pain

Beyond the preview

Go deeper on 2021-005116-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-005116-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call